Estimates Revisions Neurogene Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 20:29:04 18/05/2026 BST			5-day change	1st Jan Change
27.22 ^USD	-8.74%		-12.20%	+31.65%

05-08	Neurogene Insider Sold Shares Worth $300,043, According to a Recent SEC Filing	MT
05-06	Neurogene announces inducement grants under Nasdaq Listing Rule 5635(c)(4)	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
NEUROGENE INC.	-	-
LONZA GROUP AG
BEONE MEDICINES AG
REVOLUTION MEDICINES, INC.
IQVIA HOLDINGS INC.
CELLTRION, INC.
ASCENDIS PHARMA A/S			-
IONIS PHARMACEUTICALS, INC.
EUROFINS SCIENTIFIC SE
Average
Weighted average by Cap.